Search clinical trials for: Part 2 (Fed): Treatment A
Total 2349 results
-
PfizerCompletedRheumatoid Arthritis | Healthy VolunteersUnited States
-
AstraZenecaAcerta Pharma, LLCCompletedBioavailability | B-cell Lymphoid CancerUnited States
-
PfizerCompletedNeurogenic Detrusor OveractivityBelgium
-
Chong Kun Dang PharmaceuticalCompletedType2 Diabetes MellitusKorea, Republic of
-
Daiichi Sankyo, Inc.CompletedHealthy VolunteersUnited States
-
Ferring PharmaceuticalsRecruitingInflammatory Gastrointestinal DiseasesGermany
-
Kowa Company, Ltd.Completed
-
Huahui HealthCompleted
-
Beijing Biostar Pharmaceuticals Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Novartis PharmaceuticalsActive, not recruitingSickle Cell DiseaseUnited States
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
Bukwang PharmaceuticalActive, not recruitingParkinson Disease | DyskinesiasUnited States
-
Janssen Cilag N.V./S.A.CompletedHealthy VolunteersUnited Kingdom
-
Kanyos Bio, Inc., a wholly-owned subsidiary of...PfizerRecruitingCeliac DiseaseUnited States, Australia, New Zealand
-
Czech Lymphoma Study GroupHoffmann-La Roche; Ministry of Health, Czech RepublicCompletedDiffuse Large B-Cell Lymphoma. | Primary Mediastinal B-Cell Lymphoma | Follicular Lymphoma Grade IIICzech Republic
-
Sun Pharmaceutical Industries LimitedCompletedScalp PsoriasisUnited States, Australia
-
Merck Sharp & Dohme LLCTerminatedAlzheimer's Disease | Amnestic Mild Cognitive Impairment | Prodromal Alzheimer's Disease
-
Yonsei UniversityRecruitingStrokeKorea, Republic of
-
AstraZenecaParexelRecruiting
-
Verona Pharma plcIqvia Pty LtdCompleted
-
Hoffmann-La RocheCompleted
-
Eli Lilly and CompanyCompleted
-
ImmunityBio, Inc.RecruitingQUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid TumorsMetastatic Solid TumorUnited States
-
Actimed Therapeutics LtdQuotient SciencesCompleted
-
AstraZenecaCompletedGonococcal (GC) InfectionUnited States
-
GLWL Research Inc.TerminatedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedPrimary Biliary CholangitisUnited States, Germany, Russian Federation, Canada, United Kingdom, Poland
-
Tufts UniversityTufts Medical Center; Saint Elizabeth's Medical CenterCompletedRenal Insufficiency, Chronic | Kidney Failure, ChronicUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSmall Cell Lung CancerChina
-
Janssen Research & Development, LLCCompletedHealthy | Asthma | Atopic DermatitisGermany, Belgium
-
HvivoPfizerRecruiting
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedCystic Fibrosis | Non-Cystic Fibrosis BronchiectasisBelgium
-
Verona Pharma plcIqvia Pty LtdCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Emory UniversityTerminatedSickle Cell DiseaseUnited States
-
Mereo BioPharmaNovartisTerminatedAcute Kidney InjuryTaiwan, United States, Israel
-
Genentech, Inc.CompletedHealthy VolunteersUnited States
-
Bausch & Lomb IncorporatedCompleted
-
University of PittsburghDalhousie University; National Institute on Disability, Independent Living,...RecruitingWheelchair SkillsUnited States
-
University of UlsterUniversity College Dublin; University College CorkCompletedAntioxidant Status, InflammationUnited Kingdom
-
Bilthoven BiologicalsSerum Institute of India Pvt. Ltd.CompletedImmune Response to Oral Polio VaccineBangladesh
-
Sun Pharma Advanced Research Company LimitedTerminatedAdvanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States, India
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Trevena Inc.TerminatedMigrainesUnited Kingdom
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
FA CorporationUniversity of Texas Southwestern Medical CenterEnrolling by invitation